X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Sun Pharma Advanced Research Company Ltd.
BSE CODE: 532872   |   NSE CODE: SPARC   |   ISIN CODE : INE232I01014   |   18-May-2024 12:50 Hrs IST
BSE NSE
Rs. 219.55
3.4 ( 1.57% )
 
Prev Close ( Rs.)
216.15
Open ( Rs.)
223.75
 
High ( Rs.)
223.75
Low ( Rs.)
216.35
 
Volume
4662
Week Avg.Volume
195903
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 219.20
2.9 ( 1.34% )
 
Prev Close ( Rs.)
216.30
Open ( Rs.)
217.25
 
High ( Rs.)
221.00
Low ( Rs.)
216.80
 
Volume
126895
Week Avg.Volume
695385
 
52 WK High-Low Range(Rs.)
178.8
472.8
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)-6.86  -7.48  -5.77  -11.92  -5.55  
   CEPS(Rs)-6.50  -7.11  -5.35  -11.56  -5.26  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)15.80  -7.47  -6.42  -0.71  11.30  
   Tax Rate(%)0.00  0.00  0.00  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)-89.65  -136.07  -53.36  -403.58  -82.73  
   EBIT Margin(%)-90.02  -138.48  -55.54  -403.22  -79.48  
   Pre Tax Margin(%)-93.22  -148.19  -59.75  -406.70  -79.53  
   PAT Margin (%)-93.22  -148.19  -59.75  -406.70  -79.53  
   Cash Profit Margin (%)-88.29  -140.79  -55.43  -394.36  -75.40  
Performance Ratios          
   ROA(%)-40.10  -79.80  -60.18  -93.11  -40.89  
   ROE(%)-143.72  0.00  0.00  -225.08  -74.72  
   ROCE(%)-69.44  -225.57  -254.10  -178.95  -59.95  
   Asset Turnover(x)0.43  0.54  1.01  0.23  0.51  
   Sales/Fixed Asset(x)1.71  1.07  1.96  0.71  2.48  
   Working Capital/Sales(x)0.87  -1.37  -1.46  -0.46  1.13  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.58  0.93  0.51  1.40  0.40  
   Receivable days46.20  60.25  24.26  62.28  27.67  
   Inventory Days0.00  0.00  0.00  0.00  0.00  
   Payable days0  0  0  0  0  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  0.00  
   PCE(x)-27.62  -41.77  -26.48  -8.35  -36.49  
   Price/Book(x)11.36  -39.75  -22.07  -135.68  16.98  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)23.92  59.34  15.55  33.79  27.52  
   EV/Core EBITDA(x)-28.11  -45.27  -30.37  -8.64  -36.52  
   EV/EBIT(x)-26.57  -42.85  -28.01  -8.38  -34.63  
   EV/CE(x)6.88  29.08  17.13  9.52  12.63  
   M Cap / Sales24.39  58.81  14.68  32.92  27.51  
Growth Ratio          
   Net Sales Growth(%)73.98  -45.74  229.31  -57.99  133.67  
   Core EBITDA Growth(%)-12.94  -38.85  56.85  -117.91  42.03  
   EBIT Growth(%)-13.09  -35.29  54.64  -113.11  26.18  
   PAT Growth(%)-9.43  -34.58  51.62  -114.81  26.18  
   EPS Growth(%)8.32  -29.71  51.62  -114.81  29.31  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  -0.37  -1.37  -3.59  0.01  
   Current Ratio(x)2.54  0.42  0.26  0.29  2.71  
   Quick Ratio(x)2.54  0.42  0.26  0.29  2.71  
   Interest Cover(x)-28.15  -14.26  -13.19  -115.79  -1547.78  
   Total Debt/Mcap(x)0.00  0.01  0.06  0.03  0.00